The findings provide further support of recommendations in the clinical guidelines to favor one therapy over the other. Patients with chronic obstructive pulmonary disease (COPD) being treated with ...

Through the first four games of the season, Noah Laba has stood out for the New York Rangers. Laba’s impressive play unexpectedly became the headline at training camp, as a once-considered lock to ...

Read the recent NHL news and rumors about Noah Laba for fantasy hockey. New York Rangers center Noah Laba (lower body) won't ...

_ A phase II multi-dose study shows fast-acting and long-lasting efficacy of LAS100977, Almirall_s novel once-daily inhaled beta2 agonist (LABA), for the treatment of bronchoconstriction in asthmatic ...

Please provide your email address to receive an email when new articles are posted on . Inhalers with a long-acting muscarinic antagonist and a long-acting beta agonist (LABA) resulted in “better ...

One player every New York Rangers fan was keeping an eye on this season was Noah Laba. After a strong preseason showing, the 22-year-old center earned a spot on the opening night roster. Since getting ...

Previous phase 3 studies have demonstrated the efficacy of nebulized glycopyrrolate inhalation solution (GLY) for treating patients with chronic obstructive pulmonary disease (COPD). In a recent study ...

Way back in the first few days of training camp, new Rangers coach Mike Sullivan talked about the idea of forward duos, like Mika Zibanejad and J.T. Miller, or Artemi Panarin and Vincent Trocheck, as ...

Please provide your email address to receive an email when new articles are posted on . Moving from a low-dose inhaled corticosteroid to a medium-dose inhaled corticosteroid plus a long-acting beta ...